British-based company Medick is offering consumers in the UK its MHM100 personal ECG monitor, a device the company calls the “world’s first intelligent personal ECG heart monitor,” and an internet-based service that comes with the device:
The MHM100 personal ECG monitor offers the public at home ECG monitoring with access to a cardiology centre via a web based subscription service to analyse the reports generated by the monitor. The MHM 100 is available from www.medick.com for a purchase price of £295 and the monthly subscription reporting service is priced at just £12 per month for six expert analyses per year. As well as monitoring the rhythm of the heart in real time, the monitor allows users to directly see the impact of everything from smoking and caffeine through to exercise on the heart’s performance.
The MHM 100 monitor uses three electrodes to capture the heart’s rhythms for up to 8 hours at a time and requires no specialist medical knowledge to use it. The product has been developed to allow people who either already have a heart condition or are worried about developing a potential heart condition to monitor the rhythms of their heart as they go about their daily routine. Until now, such monitoring would usually require a visit to a GP or hospital. The monitor is also ideal for those concerned about a partner or family member who may be at risk from cardiovascular disease.
The subscription based reporting service features an easy to understand traffic light system and allows users to download the results of their tests. The reports are analysed by physicians who specialise in the reading of ambulatory ECGs. Furthermore if any specific issues are identified, the report is then passed to a cardiologist for further analysis.
In addition, MHM 100 users can view their heartbeat on the monitor’s built in display or download the results of the test onto a computer and view the waveforms. This latter feature is especially useful for those who do have a Heart condition and wish to learn more about how to best manage their condition and performance of their Heart.
The MHM 100 is capable of detecting a wide range of potentially serious arrhythmias such as tachycardia (including VT), bradycardia, atrial and ventricular ectopics, pauses, and AF, as well as ST segment depression events.
This clinician wonders about the diagnostic ability of this device to detect ST segment depressions. With only 3 leads, the ST segment detection would not be very sensitive. Or would it?